ReviewCNS & neurological disorders drug targets2010

Prime time for G-protein-coupled receptor heteromers as therapeutic targets for CNS disorders: the dopamine D₁-D₃ receptor heteromer.

Sergi Ferré et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.